title: The use of gene expression profiling and mutation analysis increases the cost of care for patients with carcinoma of unknown primary; does it also improve survival?
authors.affiliation: Medical Oncology Service, National Cancer Institute, National Institutes of Health, 10 Center Dr. 10/12N226, Bethesda, MD 20892, USA. Electronic address: prasad@ohsu.edu.
authors.forename: Vinay
authors.initials: V
authors.lastname: Prasad
authors.affiliation: Georgetown Medical School, USA.
authors.forename: Andrew
authors.initials: A
authors.lastname: Oseran
authors.affiliation: Medical Oncology Service, National Cancer Institute, National Institutes of Health, 10 Center Dr. 10/12N226, Bethesda, MD 20892, USA.
authors.forename: Farhad
authors.initials: F
authors.lastname: Fakhrejahani
mesh_terms: D002277:Carcinoma / Q000175:diagnosis* / Q000556:secondary*; D005260:Female; D020869:Gene Expression Profiling / Q000379:methods*; D006801:Humans; D008297:Male; D009382:Neoplasms, Unknown Primary / Q000175:diagnosis* / Q000235:genetics*; D020133:Reverse Transcriptase Polymerase Chain Reaction